Dr. Jimmy W Jenkins, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1102 Saint Marys Rd, Junction City, KS 66441 Phone: 785-238-0325 Fax: 785-576-1113 |
News Archive
Researchers at the Hebrew University of Jerusalem have achieved a breakthrough in monitoring the toxin-delivery system of highly pathogenic bacteria - an accomplishment that could help pave the way for new drugs that will be capable of neutralizing those germs.
"The spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue," write the authors of a Lancet Infectious Diseases review that examines what is known about the virus and progress in the development of a dengue vaccine (Webster et. al, 11/09).
Nanobiotix, a company developing novel cancer nanotherapeutics, announced today that its lead compound NBTXR3 has received the formal authorization from the French Medicine Agency, AFSSAPS, to start the first clinical trial.
Low levels of vitamin D appear to be associated with higher risk of myocardial infarction (heart attack) in men, according to a report in the June 9 issue of Archives of Internal Medicine.
Early predictors of anxiety and depression may be evident in the brain even at birth, suggests a study published in the February 2017 issue of the Journal of the American Academy of Child and Adolescent Psychiatry.
› Verified 4 days ago